Clinical Trials Browser

Completed × Uveal Melanoma × cediranib × Clear all

NCT00243061 2018-08-27

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Phase 2 Completed

24 enrolled 12 charts

Uveal Melanoma, Melanoma